Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Intranasal Administration of Human Adipose-Derived Stem Cell-Conditioned Media Ameliorates Cognitive Performance in a Rat Model of Alzheimer’S Disease Publisher



Shaker SA1 ; Parsaei H2, 3 ; Amini N4 ; Nobakht M1, 4 ; Babaei JF5 ; Dadseresht A1 ; Seidkhani E1 ; Eftekharzadeh M1, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran
  3. 3. Department of Anatomy, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
  4. 4. Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Electrophysiology Research Center, Tehran University of Medical Science, Tehran, Iran
  6. 6. Neuroscience Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Source: Physiology and Pharmacology (Iran) Published:2024


Abstract

Introduction: Alzheimer’s disease (AD) is an age-related disorder, characterized by the gradual loss of memory and cognitive function owing to neuronal damage and brain shrinkage. This study aimed to investigate how intranasal injection of human adiposederived stem cell-conditioned media (hADSC-CM) ameliorates cognitive performance and affects the level of estrogen receptor beta (Erβ) in the hippocampus of rats in an AD model. Methods: A total of 32 male rats were divided into four groups, including the control, AD model, hADSC-CM, and vehicle groups. The Morris water maze was used to assess the animals’ behavioral changes. Moreover, Nissl and Thioflavin-S staining were performed to evaluate the histology of the hippocampus. Immunohistochemistry was also carried out to evaluate the expression level of Erβ. Results: The intranasal injection of hADSC-CM improved the rats’ cognitive performance by reducing the number of dark cells and beta-amyloid plaques in the hippocampus in the AD model. Besides, the intranasal injection of hADSC-CM increased the level of Erβ in this model. Conclusion: The present findings indicated that the intranasal injection of hADSC-CM ameliorated cognitive function. Amyloid plaques and dark cells also diminished in the CA1 area of the hippocampus. Moreover, the expression level of ERβ increased. It can be concluded that hADSC-CM has significant treatment benefits for AD in rats. © 2024, Iranian Society of Physiology and Pharmacology. All rights reserved.